Rituximab in Systemic Sclerosis

NCT01748084 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: Rituximab
DRUG: Placebo (NaCl)

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]